Original Article| Volume 23, ISSUE 6, P1554-1563, July 2014

Telmisartan Reduces Progressive Oxidative Stress and Phosphorylated α-Synuclein Accumulation in Stroke-resistant Spontaneously Hypertensive Rats after Transient Middle Cerebral Artery Occlusion

      Telmisartan is an angiotensin receptor blocker with high lipid solubility, also called metabosartan, which exerts a special protective effect on both acute brain damage and chronic neurodegeneration. We examined the effects of telmisartan on oxidative stress by advanced glycation end product (AGE) and 4-hydroxynonenal (4-HNE) assays and the accumulation of phosphorylated α-synuclein (pSyn) in the brain of stroke-resistant spontaneously hypertensive rats (SHR-SR). At the age of 12 weeks, SHR-SR received transient middle cerebral artery occlusion (tMCAO) for 90 minutes and were divided into the following 3 groups: the vehicle group, the low-dose telmisartan group (.3 mg/kg/day), and the high-dose telmisartan group (3 mg/kg/day, postoperatively). Immunohistologic analysis was performed when rats were 6, 12, and 18 months old. AGE, 4-HNE, and pSyn–positive cells (per square millimeter) increased with age in the cerebral cortex and hippocampus of the vehicle group, in the low-dose telmisartan group, these parameters decreased without lowering blood pressure (BP), and in the high-dose telmisartan group, these parameters increased with lowering BP. The present study suggests that a persistent hypertension after tMCAO caused a progressive oxidative stress with the abnormal accumulation of pSyn, and that telmisartan reduced oxidative stress and the accumulation of pSyn without lowering BP (low dose) or improved these conditions with a reduction in BP (high dose) via its pleiotropic effects through a potential peroxisome proliferator–activated receptor gamma stimulation in the brain of SHR-SR.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Suematsu M.
        • Suzuki H.
        • Delano F.A.
        • et al.
        The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis.
        Microcirculation. 2002; 9: 259-276
        • Tanito M.
        • Nakamura H.
        • Kwon Y.W.
        • et al.
        Enhanced oxidative stress and impaired thioredoxin expression in spontaneously hypertensive rats.
        Antioxid Redox Signal. 2004; 6: 89-97
        • Park J.B.
        • Touyz R.M.
        • Chen X.
        • et al.
        Chronic treatment with a superoxide dismutase mimetic prevents vascular remodeling and progression of hypertension in salt-loaded stroke-prone spontaneously hypertensive rats.
        Am J Hypertens. 2002; 15: 78-84
        • Rodriguez-Iturbe B.
        • Zhan C.D.
        • Quiroz Y.
        • et al.
        Antioxidant-rich diet relieves hypertension and reduces renal immune infiltration in spontaneously hypertensive rats.
        Hypertension. 2003; 41: 341-346
        • Nishiyama A.
        • Yao L.
        • Nagai Y.
        • et al.
        Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats.
        Hypertension. 2004; 43: 841-848
        • Virdis A.
        • Neves M.F.
        • Amiri F.
        • et al.
        Spironolactone improves angiotensin-induced vascular changes and oxidative stress.
        Hypertension. 2002; 40: 504-510
        • Higashi Y.
        • Sasaki S.
        • Nakagawa K.
        • et al.
        Endothelial function and oxidative stress in renovascular hypertension.
        N Engl J Med. 2002; 346: 1954-1962
        • Abe K.
        • Yuki S.
        • Kogure K.
        Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger.
        Stroke. 1988; 19: 480-485
        • Chan P.H.
        Role of oxidants in ischemic brain damage.
        Stroke. 1996; 27: 1124-1129
        • Cui J.
        • Holmes E.H.
        • Greene T.G.
        • et al.
        Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain.
        FASEB J. 2000; 14: 955-967
        • Demopoulos H.B.
        The basis of free radical pathology.
        Fed Proc. 1973; 32: 1859-1861
        • Chung K.K.
        • Zhang Y.
        • Lim K.L.
        • et al.
        Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.
        Nat Med. 2001; 7: 1144-1150
        • Giasson B.I.
        • Duda J.E.
        • Murray I.V.
        • et al.
        Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions.
        Science. 2000; 290: 985-989
        • Schrader J.
        • Luders S.
        • Kulschewski A.
        • et al.
        Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES).
        Stroke. 2005; 36: 1218-1226
        • Ito T.
        • Yamakawa H.
        • Bregonzio C.
        • et al.
        Protection against ischemia and improvement of cerebral blood flow in genetically hypertensive rats by chronic pretreatment with an angiotensin II AT1 antagonist.
        Stroke. 2002; 33: 2297-2303
        • Unger T.
        Inhibiting angiotensin receptors in the brain: possible therapeutic implications.
        Curr Med Res Opin. 2003; 19: 449-451
        • Engelhorn T.
        • Goerike S.
        • Doerfler A.
        • et al.
        The angiotensin II type 1-receptor blocker candesartan increases cerebral blood flow, reduces infarct size, and improves neurologic outcome after transient cerebral ischemia in rats.
        J Cereb Blood Flow Metab. 2004; 24: 467-474
        • Mogi M.
        • Li J.M.
        • Iwanami J.
        • et al.
        Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2.
        Hypertension. 2006; 48: 141-148
        • Gohlke P.
        • Weiss S.
        • Jansen A.
        • et al.
        AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats.
        J Pharmacol Exp Ther. 2001; 298: 62-70
        • Maillard M.P.
        • Perregaux C.
        • Centeno C.
        • et al.
        In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
        J Pharmacol Exp Ther. 2002; 302: 1089-1095
        • Kumai Y.
        • Ooboshi H.
        • Ago T.
        • et al.
        Protective effects of angiotensin II type 1 receptor blocker on cerebral circulation independent of blood pressure.
        Experimental Neurology. 2008; 210: 441-448
        • Wienen W.
        • Schierok H.J.
        Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats.
        JRAAS. 2001; 2: 123-128
        • Korenova M.
        • Zilka N.
        • Stozicka Z.
        • et al.
        NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy.
        J Neurosci Methods. 2009; 177: 108-114
        • Sabbatini M.
        • Catalani A.
        • Consoli C.
        • et al.
        The hippocampus in spontaneously hypertensive rats: an animal model of vascular dementia?.
        Mech Ageing Dev. 2002; 123: 547-559
        • Pravenec M.
        • Landa V.
        • Zidek V.
        • et al.
        Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension.
        Physiol Res/Acad Sci Bohemoslov. 2003; 52: 681-688
        • Sanz-Rosa D.
        • Oubina M.P.
        • Cediel E.
        • et al.
        Effect of AT1 receptor antagonism on vascular and circulating inflammatory mediators in SHR: role of NF-kappaB/IkappaB system.
        Am J Physiol Heart Circ Physiol. 2005; 288: H111-H115
        • Ikeda K.
        • Negishi H.
        • Yamori Y.
        Antioxidant nutrients and hypoxia/ischemia brain injury in rodents.
        Toxicology. 2003; 189: 55-61
        • Tanaka N.
        • Ikeda Y.
        • Ohta Y.
        • et al.
        Expression of Keap1-Nrf2 system and antioxidative proteins in mouse brain after transient middle cerebral artery occlusion.
        Brain Res. 2011; 1370: 246-253
        • Fujiwara H.
        • Hasegawa M.
        • Dohmae N.
        • et al.
        alpha-Synuclein is phosphorylated in synucleinopathy lesions.
        Nat Cell Biol. 2002; 4: 160-164
        • Saito Y.
        • Kawashima A.
        • Ruberu N.N.
        • et al.
        Accumulation of phosphorylated alpha-synuclein in aging human brain.
        J Neuropathol Exp Neurol. 2003; 62: 644-654
        • Ola M.S.
        • Ahmed M.M.
        • Abuohashish H.M.
        • et al.
        Telmisartan ameliorates neurotrophic support and oxidative stress in the retina of streptozotocin-induced diabetic rats.
        Neurochem Res. 2013; 38: 1572-1579
        • Cianchetti S.
        • Del Fiorentino A.
        • Colognato R.
        • et al.
        Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells.
        Atherosclerosis. 2008; 198: 22-28
        • Xu L.
        • Liu Y.
        Administration of telmisartan reduced systolic blood pressure and oxidative stress probably through the activation of PI3K/Akt/eNOS pathway and NO release in spontaneously hypertensive rats.
        Physiol Res/Acad Sci Bohemoslov. 2013; 62: 351-359
        • Kurihara T.
        • Ozawa Y.
        • Shinoda K.
        • et al.
        Neuroprotective effects of angiotensin II type 1 receptor (AT1R) blocker, telmisartan, via modulating AT1R and AT2R signaling in retinal inflammation.
        Invest Ophthalmol Vis Sci. 2006; 47: 5545-5552